Anagnou NP - Search Results

1

Improvements in the HbVar database of human hemoglobin variants and thalassemia mutations for population and sequence variation studies.

Patrinos GP, Giardine B, Riemer C, Miller W, Chui DH, Anagnou NP, Wajcman H, Hardison RC. Patrinos GP, et al. Among authors: anagnou np. Nucleic Acids Res. 2004 Jan 1;32(Database issue):D537-41. doi: 10.1093/nar/gkh006. Nucleic Acids Res. 2004. PMID: 14681476 Free PMC article.

2

HbVar database of human hemoglobin variants and thalassemia mutations: 2007 update.

Giardine B, van Baal S, Kaimakis P, Riemer C, Miller W, Samara M, Kollia P, Anagnou NP, Chui DH, Wajcman H, Hardison RC, Patrinos GP. Giardine B, et al. Among authors: anagnou np. Hum Mutat. 2007 Feb;28(2):206. doi: 10.1002/humu.9479. Hum Mutat. 2007. PMID: 17221864

3

HbVar: A relational database of human hemoglobin variants and thalassemia mutations at the globin gene server.

Hardison RC, Chui DH, Giardine B, Riemer C, Patrinos GP, Anagnou N, Miller W, Wajcman H. Hardison RC, et al. Hum Mutat. 2002 Mar;19(3):225-33. doi: 10.1002/humu.10044. Hum Mutat. 2002. PMID: 11857738

4

Expression of embryonic globins by erythroid cells in juvenile chronic myelocytic leukemia.

Papayannopoulou T, Nakamoto B, Anagnou NP, Chui D, Dow L, Sanders J. Papayannopoulou T, et al. Among authors: anagnou np. Blood. 1991 Jun 15;77(12):2569-76. Blood. 1991. PMID: 2043763 Free article.

5

Beta-thalassemia resulting from a single nucleotide substitution in an acceptor splice site.

Atweh GF, Anagnou NP, Shearin J, Forget BG, Kaufman RE. Atweh GF, et al. Among authors: anagnou np. Nucleic Acids Res. 1985 Feb 11;13(3):777-90. doi: 10.1093/nar/13.3.777. Nucleic Acids Res. 1985. PMID: 2987809 Free PMC article.

6

A Novel BaEVRless-Pseudotyped γ-Globin Lentiviral Vector Drives High and Stable Fetal Hemoglobin Expression and Improves Thalassemic Erythropoiesis In Vitro.

Drakopoulou E, Georgomanoli M, Lederer CW, Kleanthous M, Costa C, Bernadin O, Cosset FL, Voskaridou E, Verhoeyen E, Papanikolaou E, Anagnou NP. Drakopoulou E, et al. Among authors: anagnou np. Hum Gene Ther. 2019 May;30(5):601-617. doi: 10.1089/hum.2018.022. Epub 2019 Mar 15. Hum Gene Ther. 2019. PMID: 30324804

7

Towards more successful gene therapy clinical trials for β-thalassemia.

Drakopoulou E, Papanikolaou E, Georgomanoli M, Anagnou NP. Drakopoulou E, et al. Among authors: anagnou np. Curr Mol Med. 2013 Sep;13(8):1314-30. doi: 10.2174/15665240113139990064. Curr Mol Med. 2013. PMID: 23865429 Review.

8

Use of the hereditary persistence of fetal hemoglobin 2 enhancer to increase the expression of oncoretrovirus vectors for human gamma-globin.

Fragkos M, Anagnou NP, Tubb J, Emery DW. Fragkos M, et al. Among authors: anagnou np. Gene Ther. 2005 Nov;12(21):1591-600. doi: 10.1038/sj.gt.3302566. Gene Ther. 2005. PMID: 15944728

9

Dynamic retrotransposition of ERV-9 LTR and L1 in the beta-globin gene locus during primate evolution.

Ling J, Zhang L, Jin H, Pi W, Kosteas T, Anagnou NP, Goodman M, Tuan D. Ling J, et al. Among authors: anagnou np. Mol Phylogenet Evol. 2004 Mar;30(3):867-71. doi: 10.1016/j.ympev.2003.10.004. Mol Phylogenet Evol. 2004. PMID: 15012967 No abstract available.

10

Sequences located 3' to the breakpoint of the hereditary persistence of fetal hemoglobin-3 deletion exhibit enhancer activity and can modify the developmental expression of the human fetal A gamma-globin gene in transgenic mice.

Anagnou NP, Perez-Stable C, Gelinas R, Costantini F, Liapaki K, Constantopoulou M, Kosteas T, Moschonas NK, Stamatoyannopoulos G. Anagnou NP, et al. J Biol Chem. 1995 Apr 28;270(17):10256-63. doi: 10.1074/jbc.270.17.10256. J Biol Chem. 1995. PMID: 7537267 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

144 results

Search Page

Filters